Imprecise use of medication contributes to an estimated 45 to 50 million adverse drug events (ADEs) annually and is the 4th leading cause of death in the U.S. NJHA Strategic Partner Tabula Rasa Healthcare (TRHC) provides patient-specific data-driven technology and solutions that enable healthcare organizations to optimize medication regimens, improve outcomes, reduce hospitalizations and manage risk.

Medication safety solutions are TRHC's lead offerings for NJHA members. TRHC augments prescribing by taking patient specific factors like labs, genomics and personal history and interpreting them with algorithms and medication decision tools to support precision dosing functionality. TRHC’s proprietary system for Medication Risk Stratification™ identifies patients who are at the highest risk for an ADE so clinicians can target medication safety interventions. The medication safety tool, MedWise Advisor®, is the first multi-medication risk assessment and clinical decision-support platform that helps improve medication safety. MedWise Advisor’s powerful clinical rules engine provides a visual picture of medication risk at a glance. Unlike one-to-one drug-interactions, MedWise Advisor® provides risk information for multi-drug regimens and their cumulative effects along with insight to be used for medication regimen optimization.  

Core services offered through this NJHA Business Solutions strategic partnership include:

• Continuing education accredited certification program
• Clinical escalation and support services
• Pharmacogenomic testing, interpretation and clinical application
• Comprehensive medication review communication with patients and prescribers
• MyMedWise Advisor® patient engagement mobile application

TRHC will collaborate with NJHA members to establish Centers for Personalized Medication & PrecisionPrescribing® targeted at high medication-risk individuals within the healthcare system and those interested in medication safety wellness.